Yunsen Li

1.1k total citations
49 papers, 861 citations indexed

About

Yunsen Li is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Yunsen Li has authored 49 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 13 papers in Immunology and 6 papers in Surgery. Recurrent topics in Yunsen Li's work include Glycosylation and Glycoproteins Research (14 papers), Natural product bioactivities and synthesis (11 papers) and Plant Toxicity and Pharmacological Properties (9 papers). Yunsen Li is often cited by papers focused on Glycosylation and Glycoproteins Research (14 papers), Natural product bioactivities and synthesis (11 papers) and Plant Toxicity and Pharmacological Properties (9 papers). Yunsen Li collaborates with scholars based in China, United States and Denmark. Yunsen Li's co-authors include Zijun Chen, Haiyan Liu, Qing Xie, Dapeng Zhou, Yan Wu, Steven B. Levery, Lurong Zhang, Zhengtao Wang, Bo Hu and Lijun Wen and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecular Microbiology.

In The Last Decade

Yunsen Li

48 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunsen Li China 19 569 199 120 99 88 49 861
Chunliu Mi China 22 689 1.2× 110 0.6× 86 0.7× 204 2.1× 84 1.0× 41 1.1k
Jeong‐Heon Ko South Korea 20 1.1k 2.0× 225 1.1× 74 0.6× 208 2.1× 136 1.5× 41 1.6k
Jinmei Jin China 17 584 1.0× 121 0.6× 76 0.6× 132 1.3× 57 0.6× 38 988
Mohammad Sarwar Jamal Saudi Arabia 19 467 0.8× 130 0.7× 71 0.6× 136 1.4× 82 0.9× 37 992
Jing Wei China 14 496 0.9× 119 0.6× 61 0.5× 58 0.6× 36 0.4× 61 846
Jumin Huang Macao 15 419 0.7× 136 0.7× 65 0.5× 124 1.3× 59 0.7× 25 832
Maria Rybczyńska Poland 20 603 1.1× 147 0.7× 86 0.7× 92 0.9× 83 0.9× 63 1.1k
Tomoki Yamadori Japan 13 424 0.7× 542 2.7× 43 0.4× 69 0.7× 87 1.0× 16 1.2k
Magdalena Milczarek Poland 20 336 0.6× 98 0.5× 148 1.2× 94 0.9× 76 0.9× 44 947
Kwang‐Hoe Chung South Korea 20 433 0.8× 66 0.3× 116 1.0× 77 0.8× 45 0.5× 36 963

Countries citing papers authored by Yunsen Li

Since Specialization
Citations

This map shows the geographic impact of Yunsen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunsen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunsen Li more than expected).

Fields of papers citing papers by Yunsen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunsen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunsen Li. The network helps show where Yunsen Li may publish in the future.

Co-authorship network of co-authors of Yunsen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yunsen Li. A scholar is included among the top collaborators of Yunsen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunsen Li. Yunsen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Jingjing, Dong Li, Xiaoqiang Zhu, et al.. (2024). Diterpenoid DGT alleviates atopic dermatitis–like responses in vitro and in vivo via targeting IL-4Rα. Biomedicine & Pharmacotherapy. 179. 117321–117321. 1 indexed citations
2.
Gao, Jingjing, et al.. (2024). Application and research progress of MultiBac: A review. Medicine. 103(36). e39333–e39333.
3.
Zhang, Minjie, Yunhui Yu, Dong Li, et al.. (2024). SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice. International Immunopharmacology. 134. 112234–112234. 2 indexed citations
4.
Wang, Yingjian, et al.. (2024). Copper metabolism–related signature for prognosis prediction and MMP13 served as malignant factor for breast cancer. Heliyon. 10(18). e36445–e36445. 3 indexed citations
5.
Wang, Yanping, et al.. (2024). Inhibiting glycosphingolipids alleviates cardiac hypertrophy by reducing reactive oxygen species and restoring autophagic homeostasis. Frontiers in Pharmacology. 15. 1409625–1409625. 1 indexed citations
6.
Li, Yunsen, et al.. (2024). Important molecular mechanisms in ferroptosis. Molecular and Cellular Biochemistry. 480(2). 639–658. 13 indexed citations
7.
Kong, Tingting, Shuying Wang, Jingjing Gao, et al.. (2022). Diterpenoid DGA induces apoptosis via endoplasmic reticulum stress caused by changes in glycosphingolipid composition and inhibition of STAT3 in glioma cells. Biochemical Pharmacology. 205. 115254–115254. 8 indexed citations
8.
Yang, Fei, Xiaoqiang Zhu, Liu Li, et al.. (2022). SDH, a novel diarylheptane compound, is a potential treatment for inflammatory bowel disease by restoring epithelial barrier function. Biomedicine & Pharmacotherapy. 151. 113080–113080. 4 indexed citations
9.
Li, Ling, Qing Xie, Biyan Zhang, et al.. (2020). Anti-H1N1 viral activity of three main active ingredients from zedoary oil. Fitoterapia. 142. 104489–104489. 22 indexed citations
10.
Wang, Mengfei, Tong Zhang, Ling Li, et al.. (2020). Protective effects of HY1702 on lipopolysaccharide-induced mild acute respiratory distress syndrome in mice. European Journal of Pharmacology. 887. 173563–173563. 5 indexed citations
12.
Ju, Linling, Yanping Wang, Qing Xie, et al.. (2015). Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer. Glycobiology. 26(5). 460–471. 26 indexed citations
13.
Yu, Yunhui, et al.. (2013). The relationship of the expression level of glycosphingolipids in human glioblastoma cell line A172, U251 and U251/VM-26 and drug resistance. Zhonghua shenjing waike zazhi. 29(10). 1067–1072. 1 indexed citations
14.
Yung, Gisella Puga, Yunsen Li, Lubor Borsig, et al.. (2012). Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock‐out pigs. Xenotransplantation. 19(3). 196–206. 19 indexed citations
15.
Li, Yunsen, et al.. (2010). Mass spectrometry of fluorocarbon‐labeled glycosphingolipids. Journal of Mass Spectrometry. 45(5). 504–519. 18 indexed citations
16.
Li, Yunsen, Susann Teneberg, Prakash Thapa, et al.. (2007). Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry. Glycobiology. 18(2). 158–165. 52 indexed citations
17.
Li, Yunsen. (2005). Benzofuran compounds from Ligularia caloxantha. Zhongcaoyao. 2 indexed citations
18.
Zhou, Hui, et al.. (2004). Serratane-type Triterpenoids fromHuperzia Serrata. Natural Product Research. 18(5). 453–459. 25 indexed citations
19.
Li, Yunsen, Ji‐Jun Chen, Hui Zhou, et al.. (2003). Two New Guaianolides and a New Daucene Derivative fromSinodielsia yunnanensis. Planta Medica. 69(10). 962–964. 1 indexed citations
20.
Li, Yunsen. (2002). Study on identification of terpenes from Ligulria kanaitzensis. Zhōnghuá yàoxué zázhì. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026